Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer

Medical Science Monitor

Volumn 11, Issue 8, 2005, Pages

  Kosmas, Christos ^a,c   Tsavaris, Nicolas B ^b   Tsakonas, George ^a   Soukouli, Georgia ^a   Gassiamis, Argyris ^a   Mylonakis, Nicolas ^a   Karabelis, Athanasios ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c NONE   (Greece)

Author keywords

Breast cancer; Carcinomatous meningitis; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTARABINE; METHOTREXATE; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CYTOLOGY; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; RELIABILITY; TREATMENT OUTCOME;

AGED; BREAST NEOPLASMS; HUMANS; MENINGEAL NEOPLASMS; MENINGITIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 24044433941     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Posner JB: Neurologic Complications of Cancer. Philadelphia, PA, FA. Davis Company 1995; 143-68
2. Yap BS, Yap HY, Fritsche HA et al: CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer. JAMA, 1980; 244: 1601-3
3. Glantz MJ, Cole BF, Glantz LK et al: Cerebrospinal fluid cytology in patients with cancer, minimizing false-negative results. Cancer, 1998; 82: 733-39
4. Glantz MJ, Jaeckle KA, Chamberlain MC et al: A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res, 1999; 5: 3394-402
5. Bagshawe KD, Harland SJ: Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer, 1976; 38: 112-18
6. van Oostenbrugge RJ, Hopman AHN, Arends JW et al: Treatment of leptomeningeal metastases evaluated by interface cytogenetics. J Clin Oncol, 2000; 18: 2053-58
7. Stockhammer G, Poewe W, Burgstaller S et al: Vascular endothelial growth factor in CSF. A biological marker for carcinomatous meningitis. Neurology, 2000; 54: 1670-75